HLS Therapeutics (HLTRF) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.18
-0.15
-0.12
-0.09

Details

Expected EPS
-0.119776
Actual EPS
-0.14
Surprise EPS
-0.02
Surprise Percent
-16.88%

Description

⁨HLS Therapeutics⁩ (⁦HLTRF⁩) has reported earnings of ⁦-0.14⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts